On July 30, SKB BIO declined 3.01% in regular trading, trading at 482.6 HKD/share, with Turnover of 58.98 million HKD.
Within the Biotechnology sector where SKB BIO belongs, the overall sector showed broad weakness. Among individual stocks, INNOVENT BIO down 1.73%, AKESO down 2.04%, BEIGENE down 1.51%, 3SBIO down 1.95%, REMEGEN down 3.38%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)